[Retracted] Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis

Figure 5

Forest diagram: anti-EGFR regimen plus standard treatment and standard treatment alone. Results: locoregional recurrence-free survival (LRRFS) rate.